How can healthcare providers trust that the AI imaging solutions they’re adopting are safe, effective, and tailored to their needs? I had the chance to interview Jaishree Naidoo, CEO of Envisionit Deep AI® about Ratify at HLTH USA, an innovative platform offering real-time post-market surveillance and validation of AI tools in healthcare.

Unlike FDA approvals, which are based on retrospective evaluations, Ratify enables ongoing monitoring, allowing healthcare providers to choose the right AI solution for specific patient demographics and clinical environments. This approach not only minimizes risk but also ensures AI solutions remain unbiased and accurate over time. Check out our conversation to learn more about how Ratify empowers healthcare providers and AI companies alike.

hashtag#hleathai hashtag#aiimaging hashtag#hlth2024 hashtag#innovation

Hosted on Acast. See acast.com/privacy for more information.